HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Aug. 9, 2022 (HealthDay News) -- This discovery is nothing to sniff at.
The linings of kids' noses are better able than those of adults to guard against SARS-CoV-2 infection, Australian researchers report.
“Children have a lower COVID-19 infection rate and milder symptoms than adults, but the reasons for this have been unknown,” said study co-author Kirsty Short, of the University of Queensland. “We’ve shown the lining of children’s noses has a more pro-inflammatory response to the ancestral SARS-CoV-2 than adult noses.”
She said researchers found major differences by age when comparing participants' response to COVID variants. They recently published their findings in the journal PLOS Biology.
For the study, they exposed samples of nasal lining cells from 23 healthy children and 15 healthy adults to SARS-CoV-2. The virus replicated less effectively in the children's cells and the antiviral response was greater, researchers found.
There are several possible explanations, Short said.
“It could be an adaptation to the increased threats of ‘foreign invaders’ such as viruses or bacteria observed in childhood,” she said. “It’s also possible that increased exposure to these threats in childhood ‘trains’ the nasal lining in children to mount a stronger pro-inflammatory response.”
Short added that the expression of virus-fighting genes may change due to metabolic differences between children and adults.
Interestingly, the study found that the Delta variant of COVID was significantly less likely to replicate in kids' nasal cells than in adults'. This pattern, however, was noticeably less pronounced with the more contagious Omicron variant that is now predominant around the world.
“Taken together, it shows children’s nasal lining supports lower infection and replication of ancestral SARS-CoV-2, but this may be changing as the virus evolves,” Short said.
She said more research in a larger population is needed to validate these findings and to determine the role of other factors such as antibodies in protecting children from SARS-CoV-2 infection.
For more about how SARS-CoV-2 spreads through the nose and respiratory tract, visit the University of North Carolina Gillings School of Global Public Health.
SOURCE: University of Queensland, news release, Aug. 3, 2022
- What Does 'Long COVID' Look Like in Kids? - Consumer Health ... ›
- Which Kids Are Most Vulnerable to Severe COVID-19? - Consumer ... ›
- COVID Hospitalizations Rising in Kids Too Young for Vaccine ... ›
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on September 21, 2022